GlassScriptPhysician profile
Cameron Koester
NPI 1831619022
$637.05
in general payments reported to CMS, 2019-2025
16 companies · $293 in 2025
The $293 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $31.96 · 2022: $141 · 2023: $59.11 · 2024: $112 · 2025: $293.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $464.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $464.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $140.65 | 2022 | |
| Boston Scientific Corporation | $136.21 | 2025 | Accolade Sr |
| Pfizer INC. | $58.35 | 2025 | |
| Scpharmaceuticals INC. | $41.71 | 2024-2025 | |
| Actelion Pharmaceuticals US, INC. | $41.20 | 2023 | Uptravi, Opsumit |
| Astrazeneca Pharmaceuticals LP | $37.32 | 2024-2025 | Wainua, Farxiga |
| Novo Nordisk INC | $23.29 | 2024 | Ozempic |
| Edwards Lifesciences Corporation | $20.76 | 2025 | Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Novartis Pharmaceuticals Corporation | $20.05 | 2021 | |
| Janssen Scientific Affairs, LLC | $18.96 | 2024 | Xarelto |
| E.R. Squibb & Sons, L.L.C. | $18.60 | 2025 | Camzyos |
| Boehringer Ingelheim Pharmaceuticals, INC. | $17.91 | 2023 | Jardiance |
| Lexicon Pharmaceuticals, INC. | $17.70 | 2024 | |
| Cvrx, INC. | $16.57 | 2024 | Barostim Neo System |
| Merck Sharp & Dohme LLC | $15.86 | 2025 | Verquvo |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $11.91 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cameron Koester listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.